Susceptibility testing of Streptococcus mitis group isolates

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 257-261

  Bancescu, G ^b   Dumitriu, S ^b   Bancescu, Adrian ^b   Defta, C ^b   Pana, M ^a   Ionescu, D ^b   Alecu, S ^b   Zamfirescu, M ^b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b CANTACUZINO INSTITUTE   (Romania)

Author keywords

Antimicrobial susceptibility; Oral and maxillofacial infections; Streptococcus gordonii; Streptococcus mitis; Streptococcus oralis; Streptococcus sanguis

Indexed keywords

AMPICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; HUMAN; ITALY; MAXILLOFACIAL DISORDER; MINIMUM INHIBITORY CONCENTRATION; MOUTH INFECTION; PUS; SPECIES IDENTIFICATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS;

EID: 3442892404     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ghitescu I. Antibiotherapy in dentistry. Bucharest: Cerma, 1997.
2. Lewis MAO, Meechan CM, MacFarlane TW, Lamey PJ, Kay EJ. Presentation and antimicrobial treatment of acute oro-facial infections in general dental practice. Br Dent J 1989; 166: 41-5.
3. Lewis MAO, MacFarlane TW, McGowan DA. A microbiology and clinical review of the acute dentoalveolar abscess. Br J Oral Maxillofacial Surg 1990; 28: 359-66.
4. Lewis MAO, Parkhurst CL, Douglas CWI, Martin MV, Absi EG, Bishop PA, et al. Prevalence of penicillin resistant bacteria in acute suppurative oral infection. J Antimicrob Chemother 1995; 35: 785-91.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Ninth informational supplement: Approved Standard M100-S8. Wayne PA: NCCLS; 1999 p. 90-3.
6. Knapp CC, Washington JA. Comparison of the E test and microdilution for detection of β-lactam-resistant mutants streptococci that are stably derepressed for type 1 β-lactamase. J Clin Microbiol 1992; 30: 214-5.
7. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996; 40: 891-4.
8. Renneberg J, Niemann LL, Gutschik E. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. J Antimicrob Chemother 1997; 39: 135-40.
9. Konig A, Reinert RR, Hakenbeck R. Streptococcus mitis with unusually high level resistance to beta-lactam antibiotics. Microb Drug Resist 1998; 4: 45-9.
10. Teng LJ, Hsueh PR, Chen YC, Ho SW, Luh KT. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother 1998; 41: 621-7.
11. Wisplinghoff H, Reinert RR, Cornely O, Seifert H. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol 1999; 37: 1876-80.
12. Alcaide F, Carrantala J, Linares J, Gudiol F, Martin R. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob Agents Chemother 1996; 40: 2117-20.
13. Traub WH, Leonhard B. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs. Chemother 1997; 43: 123-31.
14. Ono T, Shiota S, Hirota K, Nemota K, Tsuchiya T, Miyake Y. Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrob Agents Chemother 2000; 44: 1078-80.